
2027 年亚太地区微导管市场预测 - COVID-19 影响和按适应症(神经血管、冠状动脉和一般外周血管)和最终用户(医院、专科诊所和门诊手术中心)进行的区域分析
No. of Pages: 114 | Report Code: TIPRE00022147 | Category: Life Sciences
No. of Pages: 114 | Report Code: TIPRE00022147 | Category: Life Sciences
微导管被描述为用于微创应用的薄壁、小直径导管和输送装置。这些小型导管非常适合在体内发现的巨大的微小静脉网络中导航。
亚太地区微导管市场预计将从2019年的8505万美元增至2027年的1.6698亿美元;预计 2020 年至 2027 年复合年增长率为 8.9%。市场增长归因于心血管和神经血管疾病等慢性疾病的患病率显着增加,以及亚太地区老年人口的增加。然而,产品召回、严格的监管要求以及专业人士的缺乏阻碍了市场的增长。
微导管是微创应用中使用的输送设备。这些小型导管非常适合在体内发现的巨大的微小静脉网络中导航。据世界卫生组织(WHO)称,心血管疾病(CVD)是全世界发病和死亡的最主要原因。 CVD包括脑血管病、冠心病、风湿性心脏病等。根据世界卫生组织2017年发布的数据,2016年约有1790万人死于心血管疾病,占当年全球死亡人数的31.0%。因此,亚太地区心血管疾病发病率的显着上升可能会推动对治疗这些疾病所需的设备(例如微导管)的需求。此外,近年来,亚太地区脑动脉瘤等神经系统疾病的患病率显着增加,这刺激了对治疗过程中使用的微导管的需求。此外,老年人口的增加导致心血管疾病和神经系统疾病的增加,这促进了亚太地区微导管市场的增长。
亚太地区国家正面临挑战由于 COVID-19 的发病率不断增加。疫情爆发限制了供应链运作。此外,由于医疗基础设施短缺以及 COVID-19 病例激增对神经血管设备的需求减少,低收入国家面临着额外的挑战。一些国家采取的全面封锁等限制性措施正在限制这些国家的供应链和医疗设备的供应。因此,商业活动中的障碍(例如实施完全封锁)阻碍了各种技术先进的医疗保健系统(包括微导管)的采用。
亚太地区微导管市场按适应症分为神经血管、冠状动脉和一般外周血管。 2019 年,冠状动脉细分市场占据最大市场份额,预计该细分市场在预测期内的复合年增长率最高。
基于最终用户亚太地区微导管市场分为医院、专科诊所和门诊手术中心。医院细分市场在 2019 年占据最大的市场份额,预计该细分市场在预测期内的复合年增长率最高。
span>
一些主要来源与本报告有关亚太地区微导管市场相关的二手资料包括意大利医学和科学协会联合会 (FISM)、意大利神经科学协会 (SINS) 和世界中风协会组织 (WSO)。
Strategic insights for Asia Pacific Microcatheters involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 85.05 Million |
Market Size by 2027 | US$ 166.98 Million |
Global CAGR (2020 - 2027) | 8.9% |
Historical Data | 2017-2018 |
Forecast period | 2020-2027 |
Segments Covered |
By 适应症
|
Regions and Countries Covered | 亚太地区
|
Market leaders and key company profiles |
The regional scope of Asia Pacific Microcatheters refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies - Asia Pacific Microcatheters Market
The Asia Pacific Microcatheters Market is valued at US$ 85.05 Million in 2019, it is projected to reach US$ 166.98 Million by 2027.
As per our report Asia Pacific Microcatheters Market, the market size is valued at US$ 85.05 Million in 2019, projecting it to reach US$ 166.98 Million by 2027. This translates to a CAGR of approximately 8.9% during the forecast period.
The Asia Pacific Microcatheters Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Microcatheters Market report:
The Asia Pacific Microcatheters Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Microcatheters Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Microcatheters Market value chain can benefit from the information contained in a comprehensive market report.